About HDT Bio
HDT Bio is a biopharmaceutical company developing drugs for immunotherapy of cancers and infectious diseases.
Founded in 2018 by Christopher Pirie and Steven Reed.
- Founded
- 2018
- Employees
- 11 to 50
- Total funding
- $70M
- Headquarters
- Seattle
Leadership
The top of HDT Bio's org chart, with how many people report into each leader.
SR
Steve Reed
Co-Founder & CEO
33 reports
PB
Peter Berglund
CSO
23 reports
CM
Curt Malloy
Sr Vice President, Strategic Operations
6 reports
BP
Barbara Purmort
Director, Human Resources
LB
Loren Beck
CLO
Board
AL
André Lieber
Advisor
DF
Deborah H. Fuller
Scientific Advisor
JB
John Ballantyne
Director
NM
Neal Mody
Co-Founder & Director
DC
Darrick Carter
Scientific Co-Founder
RC
Rhea Coler
Scientific Advisor
Jobs at HDT Bio
No open positions right now. Explore more companies on TheJobsMap.